Close

Standpoint Research Downgrades Medifast (MED) to Hold; Taking Profits; Possible Switch Into WTW

July 9, 2012 10:20 AM EDT Send to a Friend
Standpoint Research downgraded Medifast (NYSE: MED) from Buy to Hold with a price target of $24.00.

Analyst, Ronnie Moas ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login